Partnerships

We focus on clinic-ready compounds and can accommodate a wide range of partnering structures. Our approach allows us to determine the best drug candidates without any inherent internal biases, thus circumventing the potential challenges and low probabilities of success associated with early research efforts.
Contact us at oib.e1746513480rof@r1746513480entra1746513480p1746513480 to discuss a potential collaboration.